 Neurodegenerative Diseases
"Neurodegenerative Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Descriptor ID |
D019636
|
| MeSH Number(s) |
C10.574
|
| Concept/Terms |
Neurodegenerative Diseases- Neurodegenerative Diseases
- Neurodegenerative Disease
- Degenerative Diseases, Neurologic
- Neurologic Degenerative Disease
- Degenerative Neurologic Diseases
- Degenerative Neurologic Disease
- Neurologic Disease, Degenerative
- Neurologic Diseases, Degenerative
- Nervous System Degenerative Diseases
- Neurodegenerative Disorders
- Neurodegenerative Disorder
- Neurologic Degenerative Conditions
- Degenerative Condition, Neurologic
- Degenerative Conditions, Neurologic
- Neurologic Degenerative Condition
- Neurologic Degenerative Diseases
- Degenerative Diseases, Nervous System
- Degenerative Neurologic Disorders
- Degenerative Neurologic Disorder
- Neurologic Disorder, Degenerative
- Neurologic Disorders, Degenerative
|
Below are MeSH descriptors whose meaning is more general than "Neurodegenerative Diseases".
Below are MeSH descriptors whose meaning is more specific than "Neurodegenerative Diseases".
This graph shows the total number of publications written about "Neurodegenerative Diseases" by people in this website by year, and whether "Neurodegenerative Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2004 | 1 | 1 | 2 | | 2005 | 1 | 0 | 1 | | 2006 | 2 | 0 | 2 | | 2009 | 3 | 0 | 3 | | 2010 | 1 | 0 | 1 | | 2011 | 4 | 3 | 7 | | 2012 | 1 | 1 | 2 | | 2013 | 2 | 1 | 3 | | 2014 | 2 | 1 | 3 | | 2015 | 2 | 1 | 3 | | 2016 | 3 | 1 | 4 | | 2017 | 5 | 1 | 6 | | 2018 | 1 | 5 | 6 | | 2019 | 2 | 3 | 5 | | 2020 | 4 | 1 | 5 | | 2021 | 9 | 2 | 11 | | 2022 | 16 | 0 | 16 | | 2023 | 13 | 0 | 13 | | 2024 | 5 | 2 | 7 | | 2025 | 8 | 1 | 9 | | 2026 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Neurodegenerative Diseases" by people in Profiles.
-
Pauley ME, Coughlan C, Dong F, Bucca B, Tanner B, Chartier-Logan C, Shapiro ALB, Snell-Bergeon JK. Type 1 diabetes is associated with higher plasma levels of biomarkers of neurodegeneration and neuroinflammation. Front Immunol. 2026; 17:1860993.
-
Niemeyer CS, Nagel MA, Restrepo D, Bubak AN. HSV-1 and VZV co-reactivation: implications for worsening neurological and neurodegenerative diseases. J Neurovirol. 2026 Jul 08; 32(4).
-
Ceisel A, Graziano G, Emmerich K, Shi X, Kam TI, Flores-Bellver M, Vergara MN, Aparicio-Domingo S, Brenerman BM, Vielle A, Williams EM, Sharrock AV, Onuchuwku U, Martinez GS, Sanders LG, Nwagbo U, Wang B, Xiao H, Kroeschell G, Gao Y, Choe DJ, Clouatre CE, Carcoba DA, Reibman B, Rodriguez C, Yang K, Banerjee S, Matthews F, Thierer JH, Stein-O'Brien G, Dawson TM, Dawson VL, Ackerley DF, Canto-Soler MV, Zhang L, Mumm JS. Cell death analysis of inducible, titratable neurodegenerative disease models in zebrafish and human stem cell-derived retinal organoids. Dis Model Mech. 2026 Jul 01; 19(7).
-
Lin JLJ, Wu X, Redweik GAJ, Chiu CC, Chiu TJ, Chen YP, Webb KJ, Rani R, Lee ES, Yang WZ, Bhadra J, Stowell MHB, Yuan HS, Xue D. Resveratrol isomers with opposing activities target endonuclease G to modulate neurodegeneration and mitochondrial elimination. Proc Natl Acad Sci U S A. 2026 Jun 23; 123(25):e2534340123.
-
Camilleri MPJ, Gouzou D, Al-Wasity S, Mookiah MRK, Hernandez MV, Alex B, Tsaftaris SA, Brooks A, MacLeod R, Wu H, Bauer B, Grover C, Reel P, Krueger S, Tobin R, Steele JD, Mair G, Wardlaw J, Doney A, Trucco E, Whiteley W. A large dataset of brain imaging linked to health systems data: curation and access to a whole system national cohort from NHS Scotland. Gigascience. 2026 01 21; 15.
-
Muzaffar S, Tyagi A, Pugazhenthi S. Therapeutic Potential of Irisin in Neurodegenerative Diseases. Int J Mol Sci. 2025 Nov 24; 26(23).
-
Sanderson-Cimino M, Possin KL, Mungas DM, Paolillo EW, Asken BM, Tsoy E, Jarrott S, Cobigo Y, Saloner R, Casaletto KB, Considine C, Fields JA, Molden J, Rascovsky K, Weintraub S, Wong B, Heuer HW, Forsberg LK, Rojas JC, VandeVrede L, Ljubenkov P, Rabinovici GD, Gorno-Tempini ML, Seeley WW, Miller BL, Boeve BF, Rosen HJ, Boxer AL, Rankin KP, Kramer JH, Staffaroni AM. Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials. J Int Neuropsychol Soc. 2025 03; 31(3):242-253.
-
Ramos A, Garton ALA, Knopman J, Bossert D, Reiner AS, Alshiekh Nasany R, Reilly J, Padro-Guzman J, Konig F, Abdel-Wahab O, Rotemberg V, Lacouture M, Mahajan S, Hatzoglou V, Abramson D, Gobin YP, Francis JH, Diamond EL. Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial Chemotherapy. Neurol Neuroimmunol Neuroinflamm. 2025 Nov; 12(6):e200495.
-
Ward EL, Benowitz L, Brunner TM, Bu G, Cayouette M, Canto-Soler V, Dá Mesquita S, Di Polo A, DiAntonio A, Duan X, Goldberg JL, He Z, Hu Y, Liddelow SA, La Torre A, Margeta M, Quintana F, Shekhar K, Stevens B, Temple S, Venkatesh H, Welsbie D, Flanagan JG. Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapies. Mol Neurodegener. 2025 10 14; 20(1):108.
-
Matthews AM, Whiteley AM. UBQLN2 in neurodegenerative disease: mechanistic insights and emerging therapeutic potential. Biochem Soc Trans. 2025 08 29; 53(4):823-833.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|